Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Lantern Pharma Inc. (LTRN)

IN8bio, Inc. and Lantern Pharma Inc. are both Biotechnology companies. IN8bio, Inc. and Lantern Pharma Inc. are of similar size ($8.2M and $7.9M). Across the 8 metrics below, IN8bio, Inc. leads on 6 and Lantern Pharma Inc. on 2.

Valuation

Metric INAB LTRN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.99 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.01 0.66
EV/Sales n/m n/m 9.02
Earnings yield (231.18%) (284.21%) (32.88%)
Free cash flow yield (80.81%) (198.83%) (23.13%)

Profitability

Metric INAB LTRN Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.11%) (400.91%) (51.96%)
Return on assets (90.80%) (143.36%) (46.06%)
Return on invested capital (2,948.56%) 0.00% 0.00%

Growth

Metric INAB LTRN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 74.06% 18.65% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB LTRN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.21 1.96 4.97
Net debt to EBITDA 1.56 0.56 1.01

Dividend

Metric INAB LTRN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INAB LTRN Biotechnology median
Market cap 8.19m 7.94m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack